Zepp Health [ZEPP] vs GoPro [GPRO] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
GoPro
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Zepp Health wins in 14 metrics, GoPro wins in 4 metrics, with 0 ties. Zepp Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | GoPro | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | 21.21 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 1.86 | Zepp Health |
| Debt-to-Equity Ratio | 47.49 | 132.95 | Zepp Health |
| PEG Ratio | -2,239.00 | 7.22 | Zepp Health |
| EV/EBITDA | -105.68 | -3.25 | Zepp Health |
| Profit Margin (TTM) | -38.81% | -17.93% | GoPro |
| Operating Margin (TTM) | -10.27% | -17.65% | Zepp Health |
| Return on Equity | -28.32% | -83.57% | Zepp Health |
| Return on Assets (TTM) | -5.10% | -11.27% | Zepp Health |
| Free Cash Flow (TTM) | $-25.88M | $-129.18M | Zepp Health |
| 1-Year Return | 849.22% | 10.00% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 0.26 | GoPro |
| Enterprise Value | $4.47B | $281.40M | Zepp Health |
| EV/Revenue Ratio | 22.34 | 0.36 | GoPro |
| Gross Profit Margin (TTM) | 37.27% | 32.13% | Zepp Health |
| Revenue per Share (TTM) | $12 | $5 | Zepp Health |
| Earnings per Share (Diluted) | $-4.80 | $-0.88 | GoPro |
| Beta (Stock Volatility) | 1.12 | 1.41 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs GoPro Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | 2.26% | 80.53% | 598.28% | 860.47% | 740.83% | 746.69% |
| GoPro | 7.22% | 2.33% | 73.68% | 123.73% | 46.67% | 20.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 849.22% | 197.79% | -58.39% | -46.62% | -46.62% | -46.62% |
| GoPro | 10.00% | -80.70% | -72.67% | -97.76% | -96.31% | -96.31% |
Performance & Financial Health Analysis: Zepp Health vs GoPro
| Metric | ZEPP | GPRO |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $204.81M |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 333,011 | 37,788,140 |
| 90 Day Avg. Volume | 1,044,594 | 15,179,447 |
| Last Close | $24.85 | $1.41 |
| 52 Week Range | $2.12 - $27.86 | $0.40 - $2.37 |
| % from 52W High | -10.80% | -40.51% |
| All-Time High | $81.00 (Feb 15, 2021) | $98.47 (Oct 06, 2014) |
| % from All-Time High | -69.32% | -98.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | -0.14% |
| Quarterly Earnings Growth | 5.89% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | -0.18% |
| Operating Margin (TTM) | -0.10% | -0.18% |
| Return on Equity (TTM) | -0.28% | -0.84% |
| Debt to Equity (MRQ) | 47.49 | 132.95 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $0.70 |
| Cash per Share (MRQ) | $0.22 | $0.44 |
| Operating Cash Flow (TTM) | $-25,970,000 | $-83,924,000 |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $-27,680,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zepp Health vs GoPro
| Metric | ZEPP | GPRO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | 21.21 |
| Forward P/E | -2,239.00 | 7.22 |
| PEG Ratio | -2,239.00 | 7.22 |
| Price to Sales (TTM) | 1.61 | 0.26 |
| Price to Book (MRQ) | 1.57 | 1.86 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $204.81M |
| Enterprise Value | $4.47B | $281.40M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 0.36 |
| Enterprise to EBITDA | -105.68 | -3.25 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.41 |
| Book Value per Share (MRQ) | $14.22 | $0.70 |
Financial Statements Comparison: Zepp Health vs GoPro
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | GPRO |
|---|---|---|
| Revenue/Sales | $38.54M | $134.31M |
| Cost of Goods Sold | $24.18M | $91.16M |
| Gross Profit | $14.36M | $43.15M |
| Research & Development | $12.38M | $29.56M |
| Operating Income (EBIT) | $-18.38M | $-24.94M |
| EBITDA | $-17.79M | $-22.27M |
| Pre-Tax Income | $-19.27M | $-45.06M |
| Income Tax | $110,000 | $1.65M |
| Net Income (Profit) | $-19.74M | $-46.71M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | GPRO |
|---|---|---|
| Cash & Equivalents | $76.43M | $69.63M |
| Total Current Assets | $242.46M | $278.85M |
| Total Current Liabilities | $212.34M | $316.89M |
| Long-Term Debt | $71.16M | $16.61M |
| Total Shareholders Equity | $232.04M | $109.98M |
| Retained Earnings | $8.88M | $-728.32M |
| Property, Plant & Equipment | $9.56M | $22.93M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | GPRO |
|---|---|---|
| Operating Cash Flow | $-14.63M | $-70.72M |
| Capital Expenditures | $-2.92M | $-1.31M |
| Free Cash Flow | $-16.89M | $-58.49M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | GPRO |
|---|---|---|
| Shares Short | 308,546 | 11.25M |
| Short Ratio | 0.25 | 2.81 |
| Short % of Float | 0.05% | 0.09% |
| Average Daily Volume (10 Day) | 333,011 | 37,788,140 |
| Average Daily Volume (90 Day) | 1,044,594 | 15,179,447 |
| Shares Outstanding | 231.98M | 155.45M |
| Float Shares | 108.71M | 127.96M |
| % Held by Insiders | 0.06% | 0.04% |
| % Held by Institutions | 0.26% | 0.50% |
Dividend Analysis & Yield Comparison: Zepp Health vs GoPro
| Metric | ZEPP | GPRO |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |